PATENT CLAIM ANALYSIS

Application Number: 16420581
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "049000"]

Abstract:
The present invention provides an oral self micro-emulsifying pharmaceutical composition of a hydrophilic drug or a pharmaceutically acceptable salt thereof which, in addition to the hydrophilic drug, one or more solvents for solving the hydrophilic drug to form a drug-solvent solution and a surfactant system, further comprises one or more hydrophilic carrier which are compatible with said drug-solvent solution and the surfactant system. The oral self micro-emulsifying pharmaceutical composition of the invention exhibits comparative bioavailability to that of the hydrophilic drug through injection and is stable during storage. A method for preparing the oral self micro-emulsifying pharmaceutical composition is also provided.

Claim (Index 4):
The oral self micro-emulsifying pharmaceutical composition of  claim 1 , wherein the hydrophilic drug is gemcitabine.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.81356
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12876292', '12680335', '10585298', '09281430', '12674048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.810263602497977
- 35 USC 102 Novelty (BERT): 0.5019011180284146
- Combined Prediction Score: 0.7794273540510208
- Mean Citation Score: 236.517702
- Max Citation Score: 245.00243
- Similarity Product: 167.85850029065546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test